NC6 Stock Overview
A biomaterials company, engages in the research and development, and promotion of microbial cellulose technologies in Australia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Nanollose Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.02 |
| 52 Week High | AU$0.036 |
| 52 Week Low | AU$0.016 |
| Beta | 0.46 |
| 11 Month Change | 0% |
| 3 Month Change | -14.89% |
| 1 Year Change | -44.44% |
| 33 Year Change | -83.33% |
| 5 Year Change | -72.22% |
| Change since IPO | -91.84% |
Recent News & Updates
Recent updates
Shareholder Returns
| NC6 | AU Biotechs | AU Market | |
|---|---|---|---|
| 7D | 0% | -3.7% | -1.1% |
| 1Y | -44.4% | 19.0% | 16.1% |
Return vs Industry: NC6 underperformed the Australian Biotechs industry which returned 23.9% over the past year.
Return vs Market: NC6 underperformed the Australian Market which returned 17.9% over the past year.
Price Volatility
| NC6 volatility | |
|---|---|
| NC6 Average Weekly Movement | 19.8% |
| Biotechs Industry Average Movement | 10.3% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in AU Market | 17.7% |
| 10% least volatile stocks in AU Market | 3.6% |
Stable Share Price: NC6's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: NC6's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | n/a | www.nanollose.com |
Nanollose Limited, a biomaterials company, engages in the research and development, and promotion of microbial cellulose technologies in Australia. The company offers Nullarbor Fibre, a tree-free Nullarbor lyocell fibre for use in textiles; Jelli Grow, an alternative seed germination and plant growing material; and Nufolium that is used for nonwoven applications, such as wipes. It also offers Biollose, a soilless growing media; and MicroGel, which is developed specifically for the commercial microgreens market.
Nanollose Limited Fundamentals Summary
| NC6 fundamental statistics | |
|---|---|
| Market cap | AU$3.44m |
| Earnings (TTM) | -AU$1.16m |
| Revenue (TTM) | AU$304.04k |
11.3x
P/S Ratio-3.0x
P/E RatioIs NC6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NC6 income statement (TTM) | |
|---|---|
| Revenue | AU$304.04k |
| Cost of Revenue | AU$361.45k |
| Gross Profit | -AU$57.41k |
| Other Expenses | AU$1.10m |
| Earnings | -AU$1.16m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0067 |
| Gross Margin | -18.88% |
| Net Profit Margin | -380.40% |
| Debt/Equity Ratio | 0% |
How did NC6 perform over the long term?
See historical performance and comparison